Difficulty Concentrating or Paying Attention

Treatments Causing Difficulty Concentrating or Paying Attention

User-reported treatments that exhibited the side effect of Difficulty Concentrating or Paying Attention

Treatment	Percent of Reports
Neurontin	54%
Gabapentin (Neurontin)	54%

Below is the change in Difficulty Concentrating or Paying Attention seen after the predictor is higher than average.

Don't see what you're looking for?

Create a study and help us eradicate suffering!

Predictors

Below is the change in after the listed predictor is higher than average.

Sort by Effect Size

Sort by Confidence

% Change from Baseline*

Change from the average seen after the predictor is higher than average.

Property	Value
Variable Name	Difficulty Concentrating Or Paying Attention
Aggregation Method	MEAN
Analysis Performed At	2020-03-02
Duration of Action	24 hours
Maximum Allowed Value	5 out of 5
Minimum Allowed Value	1 out of 5
Number of Aggregate Predictors	0
Number of Aggregate Outcomes	0
Number of Measurements	0
Number of Measurements (including those generated by tagged, joined, or child variables)	0
Public	true
Onset Delay	0 seconds
Unit	1 to 5 Rating
User Variables	0
Variable Category	Symptoms
Variable ID	87183